Caren Deardorf serves as Executive at Magenta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Caren Deardorf has executed 6 insider transactions totaling $42.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 7, 2024 involved receiving (via award) 3,400 shares valued at $0.
Caren Deardorf currently holds 9,400 shares of Magenta Therapeutics, Inc. (MGTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Caren Deardorf has been a net seller of MGTA stock. They have purchased $0 and sold $42.0K worth of shares.
Caren Deardorf's most recent insider trade was on Jun 7, 2024, when they sold 3,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 30, 2022 | MGTA | $2.8K | Award | 3,000 | $0.94 | Discretionary |
| May 31, 2022 | MGTA | $3.0K | Award | 3,000 | $0.99 | Discretionary |
| Sep 16, 2021 | MGTA | $42.0K | Sale | 6,238 | $6.73 | Discretionary |
| Sep 14, 2021 | MGTA | $0 | Award | 20,000 | $N/A | Discretionary |